| 8:00 a.m. – 9:00 a.m. |
Breakfast and Registration
|
| 9:00 a.m. – 9:10 a.m. |
Introduction
Simone Sanna-Cherchi, M.D., Associate Professor of Medicine, Columbia University Irving Medical Center, New York, NY, USA
|
| 9:10 a.m. – 9:25 a.m. |
Video Presentation |
| 9:25 a.m. – 9:40 a.m. |
Recurrent FSGS: The Challenge, the Solution
Donald W. Landry, M.D., Ph.D., Chairman of Medicine Emeritus, Columbia University Irving Medical Center, New York, NY, USA
|
| 9:40 a.m. – 10:10 a.m. |
A Multifaceted Approach to Build an Innovative Therapeutic Landscape for rFSGS
Alessia Fornoni, M.D., Ph.D., Professor of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA
|
| 10:10 a.m. – 11:35 a.m. |
Patient’s Session and Q&A’s — Coming soon
|
| 11:35 a.m. – 11:45 a.m. |
Break
|
| 11:45 a.m. – 12:50 p.m. |
Political and Community Engagement — Coming soon
|
| 12:50 p.m. – 1:05 p.m. |
TBA – Morning Summary
Gary Torgow, Chairman, Huntington Bank, USA
|
| 1:05 p.m. – 1:50 p.m. |
Lunch and Group Photos
|
| 1:50 p.m. – 2:00 p.m. |
Introduction to Afternoon Sessions
Simone Sanna-Cherchi, M.D., Associate Professor of Medicine, Columbia University Irving Medical Center, New York, NY, USA
|
| 2:00 p.m. – 2:30 p.m. |
Keynote Lecture
Novel Mechanisms and Therapies for rFSGS
Moin Saleem, M.B.B.S., Ph.D., Director, Bristol Renal, University of Bristol; Founder and Chief Scientific Advisor, Purespring Therapeutics; Bristol Royal Hospital for Children, Bristol, UK |
| 2:30 p.m. – 2:45 p.m. |
Q&A and Discussion
|
| 2:45 p.m. – 3:05 p.m. |
Genetic and Non-genetic Predictors of rFSGS
Rasheed Gbadegesin, M.B.B.S., M.D., FASN, Professor of Pediatrics, Duke Molecular Physiology Institute, Duke University, Durham, NC, USA
|
| 3:05 p.m. – 3:15 p.m. |
Q&A and Discussion
|
| 3:15 p.m. – 3:35 p.m. |
Clinical Trials for rFSGS: What We Have and What We Need
Priya Verghese, M.D., M.P.H., Professor of Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago; Northwestern University Feinberg School of Medicine, Chicago, IL, USA
|
| 3:35 p.m. – 3:45 p.m. |
Q&A and Discussion
|
| 3:45 p.m. – 4:00 p.m. |
Break
|
| 4:00 p.m. – 4:20 p.m. |
Utilization of Patient-Derived Pluripotent Stem Cells and Organoids to Study rFSGS
Opeyemi Olabisi, M.D., Ph.D., Associate Professor of Medicine, Duke University, Durham, NC, USA
|
| 4:20 p.m. – 4:30 p.m. |
Q&A and Discussion
|
| 4:30 p.m. – 4:50 p.m. |
Building a Collaborative Resource to Resolve the Causes and Find New Therapies for rFSGS
Simone Sanna-Cherchi, M.D., Associate Professor of Medicine, Columbia University Irving Medical Center, New York, NY, USA
|
| 4:50 p.m. – 5:00 p.m. |
Q&A and Discussion
|
| 5:00 p.m. – 5:15 p.m. |
Current State and Future Avenues for rFSGS
Debbie Gipson, M.D., M.S., Program Director, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA |
| 5:15 p.m. – 5:30 p.m. |
Conclusions From the Organizers
|
| 5:30 p.m. |
Adjournment
|